Literature DB >> 14107997

TREATMENT OF MALIGNANT DISEASE WITH PROTAMINE SULPHATE.

A LUTTON.   

Abstract

Keywords:  BREAST NEOPLASMS; CYSTADENOCARCINOMA; LIPOSARCOMA; LYMPHATIC METASTASIS; OVARIAN NEOPLASMS; PECTORALIS MUSCLES; PHLEBITIS; PROTAMINES; THORACIC NEOPLASMS

Mesh：

Substances：

Year:  1964        PMID： 14107997     DOI： 10.1016/s0140-6736(64)92889-2

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  3 in total

1.  Protamine inhibits adenylate cyclase activity: a possible reason for the toxicity of protamine.

Authors:  Z Kiss; R Zamfirova
Journal:  Experientia       Date:  1983-12-15

2.  The action of protamine derivatives and nitrogen mustard on the growth of the Walker 256 rat carcinoma.

Authors:  W H Garvie
Journal:  Br J Cancer       Date:  1965-09       Impact factor: 7.640

3.  The effect of protamine derivatives on calcium metabolism in patients with malignancy.

Authors:  J Anderson; R W Tomlinson; J E Wright
Journal:  Br J Cancer       Date:  1967-03       Impact factor: 7.640
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.